← Eichor
Study identifier: NCT06610747 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Home- vs Hospital-based Care of Anti-VEGF Treatment for Diabetic Macular Edema: Non-inferiority RCT

Condition: Diabetic Macular Edema  ·  Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University

PhaseNA
Planned participants308
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

Diabetic macular edema (DME) is a common cause of central visual loss in diabetic patients and a global public health burden around the world. Most patients with DME and vision loss require pharmacological inhibition using anti-VEGF agents with multiple monitoring visits that require both visual acuity testing and optical coherence tomography (OCT) to determine if re-treatment is warranted as well as the recommended time interval to the next follow-up visit. However, this treatment regimen often requires monthly or every other month clinic visits, which places a substantial burden on ophthalmic clinics and patients. Recently, portable self-administered Home OCT devices have been developed that allow for home-based OCT scanning of retinal diseases, e.g., DME, although these devices do not include visual acuity determination. The investigators previously proposed to deliver Home OCT devices and Home visual acuity tester to patients\' homes to complete routine monitoring visits at home. However, there is a lack of evidence regarding the safety and efficacy of this novel monitoring regimen for DME patients, specifically whether its use could reduce the burden associated with frequent hospital visits without sacrificing visual acuity outcomes. This study aims to provide evidence to support use of a novel monitoring regimen for DME patients that could substantially reduce the burden associated with frequent hospital visits without sacrificing visual acuity outcomes.

This description comes directly from the study's public registry record.

Talk to the study team

Yingfeng Zheng, MD, PhD  ·  +8613922286455  ·  zhyfeng@mail.sysu.edu.cn

Zitian Liu, MD, PhD  ·  liuzt25@mail.sysu.edu.cn

Always discuss trial participation with your own doctor first.

Locations (4)

Dongguan Guangming Ophthalmic HospitalDongguan, Guangdong, ChinaRecruiting
The Second Peoples Hospital of FoshanFoshan, Guangdong, ChinaRecruiting
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen UniversityGuangzhou, Guangdong, ChinaRecruiting
The First Affiliated Hospital of Jinan UniversityGuangzhou, Guangdong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06610747